Cannabis compounds suppress immune defenses against gum disease bacteria through CB2 receptor pathway | Research

The takeaway

CBD, CBN, and THC all suppressed inflammatory immune responses to three major periodontal pathogens through a CB2/PI3K signaling pathway, potentially explaining why cannabis use is a risk factor for gum disease.

Cannabis users concerned about dental health, and anyone interested in how cannabis affects the immune system in specific tissue contexts.

All three major cannabinoids suppressed immune response to gum disease bacteria via CB2 pathway

What the researchers found

All three major phytocannabinoids (CBD, CBN, THC) at physiological doses suppressed pro-inflammatory cytokine release (IL-12, IL-6, IL-8, TNF) and enhanced anti-inflammatory IL-10 in response to three oral pathogens. The effect operated through a common CB2/PI3K axis. In mice, CBD suppressed P. gingivalis-induced immune markers in wild-type but not CB2 knockout mice.

Why it matters

Cannabis use is an established risk factor for periodontitis, but the mechanism was unknown. This study identifies a specific pathway: cannabinoids suppress the immune system's ability to fight the bacteria that cause gum disease, potentially allowing unchecked bacterial damage.

The numbers in context

Physiological dose: 1.0 mcg/ml. Higher doses (5+ mcg/ml) killed immune cells and inhibited some bacterial growth. CBD, CBN, and THC all suppressed IL-12 p40, IL-6, IL-8, TNF while enhancing IL-10. CB2/PI3K pathway confirmed. T. denticola was resistant to all cannabinoid doses tested.

How the study worked

In vitro study exposing human innate immune cells and gingival keratinocytes to three oral pathogens with and without phytocannabinoids at physiological doses (1.0 mcg/ml). Pathway investigated through pharmaceutical inhibition and gene silencing. In vivo verification using wild-type and CB2 knockout mice.

What this study cannot tell us

In vitro study with in vivo mouse confirmation, not human in vivo data. Physiological relevance of the doses used may vary based on consumption method. Only three oral pathogens studied. Long-term periodontal outcomes not measured.

How to read the evidence

Preliminary: rigorous in vitro work with in vivo mouse confirmation, but no human clinical data.

When this study was published

Published in 2019.

The bigger picture

Cannabis is increasingly viewed as anti-inflammatory, which is often framed as beneficial. But in the context of oral infections, suppressing inflammation means suppressing the immune defense against bacteria, potentially worsening gum disease. The same anti-inflammatory property can be harmful in certain contexts.

Questions still open

Does the route of cannabis administration (smoking vs edibles vs topical) affect oral immune suppression? Would oral probiotics counteract cannabinoid-mediated immune suppression? Is the effect reversible when cannabis use stops?

Common questions

Does cannabis cause gum disease?

This study provides a mechanism for why cannabis use is linked to gum disease: cannabinoids suppress the immune cells that fight periodontal bacteria. When the immune response is dampened, bacteria can cause more damage to gum tissue.

Is this just about smoking?

No. The study used purified cannabinoids (CBD, CBN, THC) at physiological concentrations, not smoke. The immune suppression is caused by the cannabinoids themselves interacting with CB2 receptors on immune cells, not by smoke damage.

Read the original research

Marijuana-Derived Cannabinoids Trigger a CB2/PI3K Axis of Suppression of the Innate Response to Oral Pathogens.

Frontiers in immunology, 10, 2288

View on PubMed ↗Publisher’s paper ↗

Citation

Gu, Zhen; Singh, Shilpa; Niyogi, Rajarshi G; Lamont, Gwyneth J; Wang, Huizhi; Lamont, Richard J; Scott, David A. (2019). Marijuana-Derived Cannabinoids Trigger a CB2/PI3K Axis of Suppression of the Innate Response to Oral Pathogens.. Frontiers in immunology, 10, 2288. https://doi.org/10.3389/fimmu.2019.02288